Pneumococcal polysaccharide vaccine: patient group direction template
PGD template to support the national pneumococcal polysaccharide vaccine (PPV) vaccination programme.
Applies to England
Documents
Details
This patient group direction (PGD) template supports the administration of 23-valent pneumococcal polysaccharide vaccine (PPV) to individuals from 65 years of age, and individuals from 2 years of age in a clinical risk group, in accordance with the national immunisation programme; and supports PPV administration to close contacts in accordance with UK guidelines for the public health management of clusters of serious pneumococcal disease in closed settings.
The PPV PGD version 5.00 is valid from 1 September 2024 to 1 March 2027.
Practitioners must not use this PGD template until it has been authorised in Section 2. This is a legal requirement see Human Medicines Regulations 2012. Practitioners should follow local policy/procedures to access authorised PGD documents.
This PGD template should be used with reference to current national guidance, the Green Book, and Summary of Product Characteristics for the vaccine.
Updates to this page
Published 13 September 2016Last updated 31 July 2024 + show all updates
-
Added version 5, see page 3 for change history.
-
Added version 4 - see page 2 for change history.
-
Updated template (V03.00) following routine review.
-
Added routine PGD update with indication for close contacts in a closed setting.
-
First published.